2016 China's exports of medical and health care products fell to US$55.4 billion Imports increased by 3.83%

China Medical and Health Products Import and Export Chamber of Commerce announced that according to China's customs statistics show that in 2016 China's import and export of medical and health care products 103.4 billion U.S. dollars, an increase of 0.73 percent year-on-year. Of this total, exports decreased by 1.82 per cent to $55.4 billion, imports to $48 billion, an increase of 3.83 per cent and external trade surplus of $7.4 billion, a decrease of 27.3 per cent. Excluding the impact of exchange rates, converted into RMB statistics, in 2016, foreign trade in medicine grew by 7.12%, exports by 4.41% and imports by 10.42%, leading the overall level of China's foreign trade.
Xu Ming, vice president of the China Medical and Health Products Import and Export Chamber of Commerce, said that in 2016, due to weak demand from major external economies, insufficient power in emerging markets, increasingly fierce price competition and many other factors, the import and export of pharmaceutical foreign trade into a period of low-speed growth, the difficulties and challenges faced should not be underestimated. At the same time, we also see the further optimization of the pharmaceutical export structure, the accelerated pace of internationalization of enterprises, new development momentum is accumulating, the overall development situation of pharmaceutical foreign trade is still good.
the overall foreign trade situation in 2016, the export of Chinese medicine products fell across the board.
chinese medicine products, including Chinese herbal medicine and beverage tablets, Chinese medicine, extracts and health care products exports have been negative growth, export volume and export volume "double decline." Among them, extract exports accounted for 56.2% of the total exports of Chinese medicine products, in 2016, extract exports decreased by 14.3% YoY, and exports decreased by 10.9% YoY, becoming the main reason for the negative growth of Chinese medicine exports.
western medicine exports were essentially the same as in 2015.
2016, China's imports and exports of Western pharmaceutical products amounted to US$59.87 billion, up 0.87 percent year-on-year, while exports of US$31.48 billion, a slight decline of 0.05 percent, and imports of US$28.39 billion, an increase of 1.92 percent.
the fine molecular category, exports of bulk API amounted to US$25.61 billion, basically the same as in 2015, accounting for 81.34 percent of Western medicine exports and 46.21 percent of total pharmaceutical exports. Although the volume of exports increased by 13.04 percent year-on-year, the price fell by 11.59 percent under the double blow of external pressure, and the volume increase and fall was the main tone for 2016.
exports of western pharmaceutical preparations, exports of Western pharmaceutical preparations in 2016 amounted to US$3.19 billion, a slight decline of 0.24%. In terms of export markets, in 2016, the export value of Western pharmaceutical preparations to the EU, the United States and Japan was US$436 million, US$295 million and US$65 million, respectively. Among them, exports of preparations to the U.S. market grew by more than 40%, achieving explosive growth.
medical devices, imports grew steadily and the export structure was further optimized.
, China's medical device exports are still in the long-term, the development space is relatively large. In 2016, imports and exports were $38.91 billion, up 1.1% year-on-year. Among them, imports amounted to US$18.40 billion, up 6.28% YoY, leading pharmaceutical imports. Exports amounted to US$20.50 billion, down 3.14 per cent year-on-year, with greater emphasis on quality changes in export restructuring. (Economic Watch Network)